Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-061447
Filing Date
2017-11-17
Accepted
2017-11-17 16:13:37
Documents
1
Period of Report
2017-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4078
  Complete submission text file 0001209191-17-061447.txt   5409
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 HUDSON STREET, SUITE 3610 JERSEY CITY NJ 07302
Business Address
Sukenick Scott (Reporting) CIK: 0001722886 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 171211093